Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d50a5d08fff80f620aa6f328cd9bc85e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
filingDate |
1994-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c168319e33b1c386027ac368604857f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c16c3732ef77bde5b5e1249f66fe6da |
publicationDate |
1995-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9515137-A1 |
titleOfInvention |
Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity |
abstract |
Mucosal adhesive devices are provided for use in the oral cavity for therapy against infections. The devices are dosage units which comprise a combination of antimicrobial agents such as antifungal agents and anti-inflammatory agents, optionally also a local anesthetic. The dosage units yield a gradual and relatively constant release of the pharmaceuticals over at least a 12-hour period. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9640050-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011070125-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846083-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5713852-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089559-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2335690-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005074885-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9192599-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8592434-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425892-B2 |
priorityDate |
1993-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |